Edition:
United Kingdom

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.25USD
15 Feb 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.25
Open
$7.51
Day's High
$7.51
Day's Low
$7.00
Volume
5,228
Avg. Vol
1,044
52-wk High
$9.29
52-wk Low
$6.38

Latest Key Developments (Source: Significant Developments)

Immucell Reports Q4 Loss Per Share Of $0.19
Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2018.Q4 LOSS PER SHARE $0.19.  Full Article

Immucell Corp Files For Mixed Shelf Of Up To $20 Million
Tuesday, 20 Nov 2018 

Nov 20 (Reuters) - ImmuCell Corp ::IMMUCELL CORP FILES FOR MIXED SHELF OF UP TO $20 MILLION – SEC FILING.  Full Article

ImmuCell Announces Issuance Of Human Food Safety Technical Section Complete Letter
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES ISSUANCE OF HUMAN FOOD SAFETY TECHNICAL SECTION COMPLETE LETTER FOR ITS PURIFIED NISIN PRODUCT.IMMUCELL CORP - SUBJECT TO FINAL NADA APPROVAL BY FDA, CO SEEKS TO BRING MASTITIS TREATMENT TO MARKET IN 2020.  Full Article

Immucell Sees Q2 Product Sales $3 Mln Versus $1.8 Mln
Tuesday, 10 Jul 2018 

July 10 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES PRELIMINARY SALES RESULTS FOR SECOND QUARTER OF 2018.IMMUCELL CORP - SEES Q2 PRODUCT SALES $3 MILLION VERSUS $1.8 MILLION.  Full Article

ImmuCell Q1 Loss Per Share $0.04
Monday, 14 May 2018 

May 14 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF 2018.Q1 LOSS PER SHARE $0.04.  Full Article

ImmuCell Corp Announces Pricing Of $3 Mln Public Offering Of Common Shares
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Immucell Corp ::IMMUCELL CORPORATION ANNOUNCES PRICING OF $3 MILLION PUBLIC OFFERING OF COMMON SHARES.IMMUCELL CORP - UNDERWRITTEN PUBLIC OFFERING OF 417,807 SHARES OF STOCK AT A PRICE TO PUBLIC OF $7.30 PER SHARE.IMMUCELL CORP - ALSO ANNOUNCED ESTIMATED REVENUES FOR TWELVE-MONTH PERIOD ENDED NOVEMBER 30, 2017 EXPECTED TO INCREASE BY 9% TO $10.2 MILLION.  Full Article

Immucell Q3 loss per share $0.07
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Immucell Corp ::Immucell announces financial results for third quarter of 2017.Q3 loss per share $0.07.Immucell - ‍during 3-month period ended Sept 30, 2017, total product sales were just over $2 million versus just under $2 million during same quarter of 2016​.  Full Article

No consensus analysis data available.